- Home
- LYEL vs MCB Comparison
LYEL vs MCB Comparison
Compare LYEL & MCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LYEL | MCB |
|---|---|---|
| Founded | 2018 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 745.5M | 792.6M |
| IPO Year | 2021 | 2017 |
Fundamental Metrics
Financial Performance| Metric | LYEL | MCB |
|---|---|---|
| Price | $23.39 | $82.30 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | $25.00 | ★ $90.00 |
| AVG Volume (30 Days) | ★ 133.6K | 108.0K |
| Earning Date | 11-12-2025 | 01-20-2026 |
| Dividend Yield | N/A | ★ 0.74% |
| EPS Growth | N/A | ★ 8.50 |
| EPS | N/A | ★ 5.80 |
| Revenue | $41,000.00 | ★ $261,456,000.00 |
| Revenue This Year | N/A | $15.57 |
| Revenue Next Year | N/A | $14.51 |
| P/E Ratio | ★ N/A | $14.01 |
| Revenue Growth | N/A | ★ 1.27 |
| 52 Week Low | $7.65 | $47.08 |
| 52 Week High | $45.00 | $82.48 |
Technical Indicators
Market Signals| Indicator | LYEL | MCB |
|---|---|---|
| Relative Strength Index (RSI) | 35.79 | 63.10 |
| Support Level | $22.75 | $76.58 |
| Resistance Level | $25.12 | $82.32 |
| Average True Range (ATR) | 2.58 | 2.96 |
| MACD | -1.30 | 0.09 |
| Stochastic Oscillator | 3.85 | 84.52 |
Price Performance
Historical ComparisonAbout LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.
About MCB Metropolitan Bank Holding Corp.
Metropolitan Bank Holding Corp is a bank holding company. It provides a broad range of business, commercial, and retail banking products and services to small businesses, middle-market enterprises, public entities, and individuals in the New York metropolitan area. The services provided by the company include deposits, trade finance, cash management solutions, savings, electronic banking, cards, and others. The company also provides various lending products such as acquisition loans, construction loans, and lines of credit, for retail, office, hospitality, multifamily, mixed-use, warehouse and distribution, and specialty-use properties. The bank derives its revenue in the form of interest income on loans.